Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection | |
Yang, Guo-Huan; Fan, Jia; Xu, Yang; Qiu, Shuang-Jian; Yang, Xin-Rong; Shi, Guo-Ming; Wu, Bing; Dai, Zhi; Liu, Yin-Kun; Tang, Zhao-You | |
刊名 | ONCOLOGIST
![]() |
2008 | |
卷号 | 13期号:11 |
关键词 | Osteopontin CD44 Tissue microarray Hepatocellular carcinoma Prognosis |
ISSN号 | 1083-7159 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4958428 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Yang, Guo-Huan,Fan, Jia,Xu, Yang,et al. Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection[J]. ONCOLOGIST,2008,13(11). |
APA | Yang, Guo-Huan.,Fan, Jia.,Xu, Yang.,Qiu, Shuang-Jian.,Yang, Xin-Rong.,...&Zhou, Jian.(2008).Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection.ONCOLOGIST,13(11). |
MLA | Yang, Guo-Huan,et al."Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection".ONCOLOGIST 13.11(2008). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论